Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04969835
Title A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Avacta Life Sciences Ltd
Indications

urinary bladder cancer

head and neck squamous cell carcinoma

pancreatic cancer

ovarian cancer

sarcoma

breast cancer

colorectal cancer

lung non-small cell carcinoma

Therapies

AVA6000

Age Groups: senior | adult
Covered Countries


No variant requirements are available.